Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M511112200 on January 12, 2006

J. Biol. Chem., Vol. 281, Issue 11, 7437-7444, March 17, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
281/11/7437    most recent
M511112200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edosada, C. Y.
Right arrow Articles by Wolf, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edosada, C. Y.
Right arrow Articles by Wolf, B. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Selective Inhibition of Fibroblast Activation Protein Protease Based on Dipeptide Substrate Specificity*Formula

Conrad Yap Edosada{ddagger}, Clifford Quan§, Christian Wiesmann, Thuy Tran§, Dan Sutherlin§, Mark Reynolds§, J. Michael Elliott||, Helga Raab||, Wayne Fairbrother, and Beni B. Wolf{ddagger}1

From the Departments of {ddagger}Molecular Oncology, §Medicinal Chemistry, Protein Engineering, and ||Protein Chemistry, Genentech, Inc., South San Francisco, California 94080

Fibroblast activation protein (FAP) is a transmembrane serine peptidase that belongs to the prolyl peptidase family. FAP has been implicated in cancer; however, its specific role remains elusive because inhibitors that distinguish FAP from other prolyl peptidases like dipeptidyl peptidase-4 (DPP-4) have not been developed. To identify peptide motifs for FAP-selective inhibitor design, we used P2-Pro1 and acetyl (Ac)-P2-Pro1 dipeptide substrate libraries, where P2 was varied and substrate hydrolysis occurs between Pro1 and a fluorescent leaving group. With the P2-Pro1 library, FAP preferred Ile, Pro, or Arg at the P2 residue; however, DPP-4 showed broad reactivity against this library, precluding selectivity. By contrast, with the Ac-P2-Pro1 library, FAP cleaved only Ac-Gly-Pro, whereas DPP-4 showed little reactivity with all substrates. FAP also cleaved formyl-, benzyloxycarbonyl-, biotinyl-, and peptidyl-Gly-Pro substrates, which DPP-4 cleaved poorly, suggesting an N-acyl-Gly-Pro motif for inhibitor design. Therefore, we synthesized and tested the compound Ac-Gly-prolineboronic acid, which inhibited FAP with a Ki of 23 ± 3 nM. This was ~9- to ~5400-fold lower than the Ki values for other prolyl peptidases, including DPP-4, DPP-7, DPP-8, DPP-9, prolyl oligopeptidase, and acylpeptide hydrolase. These results identify Ac-Gly-BoroPro as a FAP-selective inhibitor and suggest that N-acyl-Gly-Pro-based inhibitors will allow testing of FAP as a therapeutic target.


Received for publication, October 12, 2005 , and in revised form, December 15, 2005.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Table S1.

1 To whom correspondence should be addressed: Genentech, Inc., 1 DNA Way-MS42, South San Francisco, CA 94080. Tel.: 650-467-1954; Fax: 650-225-6327; E-mail: bbwolf{at}gene.com.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
A. M. LeBeau, W. N. Brennen, S. Aggarwal, and S. R. Denmeade
Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin
Mol. Cancer Ther., May 1, 2009; 8(5): 1378 - 1386.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-J. Lee, Y.-S. Chen, C.-Y. Chou, C.-H. Chien, C.-H. Lin, G.-G. Chang, and X. Chen
Investigation of the Dimer Interface and Substrate Specificity of Prolyl Dipeptidase DPP8
J. Biol. Chem., December 15, 2006; 281(50): 38653 - 38662.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement